Altered immune response is associated with sex difference in vulnerability to Alzheimer's disease in human prefrontal cortex
Huiying Wen,Youzhe He,Yuanchun Tang,Langjian Zhu,Quyuan Tao,Bufan Jin,Ting Luo,Yujie Peng,Yanrong Wei,Junjie Lei,Lifang Wang,Fan Wang,Fei Ling,Yue Gao,Lei Han
DOI: https://doi.org/10.1111/bpa.13318
IF: 7.611
2024-11-06
Brain Pathology
Abstract:This study analyzes four public transcriptome datasets from AD patients and age‐matched controls, revealing that the transcriptomic profile in female controls closely resembles that of AD patients. We identified a co‐expressed gene module associated with AD, sex, and aging, enriched with immune‐related functions. Notably, upregulated genes in female microglia, which substantially overlap with the co‐expressed gene module, may serve as potential biomarkers to distinguish AD from normal individuals. This work highlights the importance of sex factor in AD research and treatment strategies. Alzheimer's disease (AD) is a neurodegenerative disorder with a higher risk incidence in females than in males, and there are also differences in AD pathophysiology between sexes. The role of sex in the pathogenesis of AD may be crucial, yet the cellular and molecular basis remains unclear. Here, we performed a comprehensive analysis using four public transcriptome datasets of AD patients and age‐matched control individuals in prefrontal cortex, including bulk transcriptome (295 females and 402 males) and single‐nucleus RNA sequencing (snRNA‐seq) data (224 females and 219 males). We found that the transcriptomic profile in female control was similar to those in AD. To characterize the key features associated with both the pathogenesis of AD and sex difference, we identified a co‐expressed gene module that positively correlated with AD, sex, and aging, and was also enriched with immune‐associated pathways. Using snRNA‐seq datasets, we found that microglia (MG), a resident immune cell in the brain, demonstrated substantial differences in several aspects between sexes, such as an elevated proportion of activated MG, altered transcriptomic profile and cell–cell interaction between MG and other brain cell types in female control. Additionally, genes upregulated in female MG, such as TLR2, MERTK, SPP1, SLA, ACSL1, and FKBP5, had high confidence to be identified as biomarkers to distinguish AD status, and these genes also interacted with some approved drugs for treatment of AD. These findings underscore the altered immune response in female is associated with sex difference in susceptibility to AD, and the necessity of considering sex factors when developing AD biomarkers and therapeutic strategies, providing a scientific basis for further in‐depth studies on sex differences in AD.
pathology,neurosciences,clinical neurology